TrialClinical pharmacokinetics2020

Exposure-Response Relationships for the Efficacy and Safety of Risankizumab in Japanese Subjects with Psoriasis.

Ahmed A Suleiman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.